QuidelOrtho
QuidelOrtho Corporation, a leading player in the diagnostics industry, is headquartered in the United States and operates extensively across North America and Europe. Founded in 1979, the company has achieved significant milestones, including the merger of Quidel Corporation and Ortho Clinical Diagnostics, which enhanced its market position and product offerings. QuidelOrtho specialises in innovative diagnostic solutions, focusing on areas such as infectious disease testing, women's health, and blood typing. Their core products, including rapid diagnostic tests and laboratory instruments, are distinguished by their accuracy and speed, catering to the evolving needs of healthcare providers. With a strong commitment to quality and innovation, QuidelOrtho has established itself as a trusted name in the diagnostics sector, recognised for its contributions to improving patient outcomes globally.
DitchCarbon Score
How does QuidelOrtho's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
QuidelOrtho's score of 30 is higher than 56% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
QuidelOrtho's reported carbon emissions
In 2023, QuidelOrtho reported total carbon emissions of approximately 22,544,000 kg CO2e from Scope 1 and 29,690,000 kg CO2e from Scope 2 (market-based). This represents a decrease from 2022, where emissions were about 26,212,000 kg CO2e for Scope 1 and 28,369,000 kg CO2e for Scope 2 (market-based). The company has demonstrated a commitment to reducing its carbon footprint, although no specific reduction targets or initiatives have been disclosed in their sustainability reporting. QuidelOrtho's emissions data is self-reported and does not include Scope 3 emissions, which are often significant in the healthcare sector. The company has not cascaded any emissions data from a parent organisation, indicating that all reported figures are derived directly from QuidelOrtho Corporation. Overall, while QuidelOrtho has made strides in emissions reporting, further transparency regarding reduction targets and initiatives would enhance their climate commitment profile.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 26,212,000 | 00,000,000 |
| Scope 2 | 28,369,000 | 00,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
QuidelOrtho is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
